BUZZ-TD Cowen cuts PT on Hims & Hers, citing valuation concerns** Brokerage TD Cowen cuts price target on telehealth company Hims & Hers HIMS.N to $37 from $48, citing valuation concerns
** The new PT represents 6.6% upside to stock's last close
** Brokerage sees strong growth prospects; says telehealth platforms like HIMS are focused on personalized care, boosting subscriber adoption
** Adds co is venturing into at-home testing for more accurate and personalized care
** Three of 15 brokerages rate stock "buy" or higher, 10 "hold", two "sell"; median PT is $40, according to data compiled by LSEG
** HIMS rose ~34% in 2025
(Reporting by Sahil Pandey, Sanskriti Shekhar and Dharna Bafna in Bengaluru)
((Sahil.Pandey@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
